Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Antibiotics such as amoxicillin, ciprofloxacin, and moxifloxacin may be effective
in preventing or controlling fever and neutropenia in patients with cancer. It is not yet
known whether moxifloxacin alone is more effective than amoxicillin combined with
ciprofloxacin in treating neutropenia and fever.
PURPOSE: This randomized clinical trial is studying how well moxifloxacin works and compares
it to ciprofloxacin together with amoxicillin in treating neutropenia and fever in patients
with cancer.
Phase:
N/A
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC